Ryoko Nakagawa

Suggest Changes
Learn More
BACKGROUND Long-term maintenance of cognitive function is an important goal of treatment for Alzheimer's disease (AD), but evidence about the long-term efficacy of cholinesterase inhibitors is(More)
BACKGROUND Comparative evidence for efficacy and safety of second-generation cholinesterase inhibitors (ChEIs) is still sparse. OBJECTIVES The purpose of this research is to compare three ChEIs,(More)
  • 1